Answers are grounded in this paper and cite their sources.
Objectives. The study set out to optimize propofol synthesis parameters based on the alkylation of 4-hydroxybenzoic acid followed by decarboxylation, as well as to investigate the impurity profile in the resulting substance using high-performance liquid chromatography (HPLC) and gas chromatography (GC). Methods. The synthesis of propofol was carried out by alkylation of 4-hydroxybenzoic acid followed by decarboxylation. Optimization of the reaction conditions involved investigating the effects of reaction time, the order of reagent addition, their molar ratio, temperature, and the method of isolating the target product. The synthesized propofol was analyzed by HPLC with ultraviolet detection and by GC with mass spectrometric detection in full-scan ion current (SCAN) mode. Results. During the study, the parameters of all stages of the synthesis of high-purity propofol (2,6-diisopropylphenol) were optimized. Complete conversion of 4-hydroxybenzoic acid was achieved in approximately 3 h at 55–60°C. Subsequently, the optimal decarboxylation temperature lies in the range of 150–180°C. However, the highest purity of the propofol substance is achieved at a pressure of 9.0 mbar and a temperature of 105–108°C. Following distillation, one unidentified impurity remained in the sample. According to the results of HPLC and GC, the impurity content was 0.041% and 0.030%, respectively. Based on mass spectrometry data and additional fragmentation of propofol with the impurity, the identified impurity is hypothesized to be an unsaturated propofol analog, most likely corresponding to 2-(1-methylethenyl)-6-(1-methylethyl)phenol (Propofol impurity B, CAS 74926-89-9). For its definitive identification, further studies using an analytical standard are required. However, given the extremely low concentration of this impurity, conducting a detailed structural study was not within the scope of this research. Conclusions. As a result of optimization studies, optimal conditions were established for the synthesis of the intermediate compound, the decarboxylation step, and vacuum distillation to ensure the production of high-purity propofol. The resulting substance was analyzed using high-performance liquid and gas chromatography. Based on the obtained data, the structure of the impurity was hypothesized to be an unsaturated analogue of propofol. The content of this impurity is shown to be approximately 0.03–0.04%, which does not exceed the identification threshold established by ICH Q3A(R2). The propofol obtained can be used for the subsequent preparation of a dosage form in the form of a nanoemulsion.
No takes yet. Share an insight, caveat, or question.
Moshkov et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: